We partner with international pharmaceutical companies to act as Swiss marketing authorization holder (MAH) and commercialize innovative medicines onto the Swiss market. Our teams are highly experienced, have a long history of success and provide indepth expertise of commercial operations in therapeutic domains such as oncology and rare diseases.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2016
  • Number of employees in Switzerland
    1-9